CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 200 enrolled
Drug / intervention
Anidulafungin +1 moredrug
Likely dose
Anidulafungin 200 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00841971
NCT00841971Phase 4Completed
CompareCT.gov

Anidulafungin Versus Fluconazole for the Prevention of Invasive Fungal Infections in High-risk Liver Transplant Recipients: a Randomized, Double-blind Trial

University of Pittsburgh·interventional·Posted Feb 12, 2009·Updated Dec 17, 2014

In Brief

A Phase 4 clinical trial evaluating Anidulafungin and Fluconazole for Mycoses and 3 related conditions. Completed, enrolled 200 participants across 6 sites.

Detailed Summary

The purpose of this study is to compare the efficacy of anidulafungin versus fluconazole for the prevention of fungal diseases in liver transplant recipients

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMycoses, Fungemia, Central Nervous System Fungal Infections, Lung Diseases, Fungal
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 12, 2009
Enrollment StartFeb 1, 2010
Primary CompletionJul 1, 2013
Study CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 17.4 years ago

Interventions

Anidulafungindrug

200 mg IV loading dose followed by 100 mg qd for 21 days

Fluconazoledrug

400 mg IV for 21 days